Why we need a sector-wide emphasis on accessible health informationIn the quest to provide evidence-based health information, the importance of understandable, accessible materials can get lost in Share XWhy we need a sector-wide emphasis on accessible health informationhttps://pharmaphorum.com/views-analysis-patients/why-we-need-a-sector-wide-emphasis-on-accessible-health-information/
Bridging the gap between industry and charities: Enabling PPI in researchPublic and patient involvement (PPI) in clinical research is the new normal, but bridging the gap between how Share XBridging the gap between industry and charities: Enabling PPI in researchhttps://pharmaphorum.com/views-analysis-patients/bridging-the-gap-between-industry-and-charities-enabling-ppi-in-research/
Towards patient centricity: GSKEmbedding the patient voice into the DNA of a pharmaceutical company isn’t easy – but it is essential. Share XTowards patient centricity: GSKhttps://pharmaphorum.com/patients/towards-patient-centricity-gsk/
Giving patients a sense of belongingClinical research professional and patient advocate Kristina Wolfe tells us how pharma can collaborate better with patients and Share XGiving patients a sense of belonginghttps://pharmaphorum.com/views-analysis-patients/giving-patients-a-sense-of-belonging/
Removing logistical barriers to improve clinical trial retentionWe all know how long and arduous the clinical trial road is for sites and sponsors – but Share XRemoving logistical barriers to improve clinical trial retentionhttps://pharmaphorum.com/views-analysis-patients/removing-logistical-barriers-to-improve-clinical-trial-retention/
Towards patient centricity: PfizerIn a new series Amanda Barrell looks at how different companies are turning patient centricity into a reality. Share XTowards patient centricity: Pfizerhttps://pharmaphorum.com/views-and-analysis/towards-patient-centricity-pfizer/
Why pharma isn’t collaborating with patient organisations as much as it shouldPatient centricity has rapidly gone from a fringe idea to a fundamental principle across the industry, but are Share XWhy pharma isn’t collaborating with patient organisations as much as it shouldhttps://pharmaphorum.com/views-and-analysis/why-pharma-isnt-collaborating-with-patient-organisations-as-much-as-it-should/
The rise and rise of patient centricityGeorge Underwood looks at the rapid growth of patient centricity over the last few years and considers what Share XThe rise and rise of patient centricityhttps://pharmaphorum.com/views-and-analysis/the-rise-and-rise-of-patient-centricity/
Listening to the patient voice: Why developing new dementia treatments is everyone’s jobDeveloping life-changing treatments for dementia is a team effort that takes commitment from all involved, from charities and Share XListening to the patient voice: Why developing new dementia treatments is everyone’s jobhttps://pharmaphorum.com/views-and-analysis/listening-to-the-patient-voice-why-developing-new-dementia-treatments-is-everyones-job/
